TY - JOUR
T1 - Helium-oxygen versus air-oxygen noninvasive pressure support in decompensated chronic obstructive disease
T2 - A prospective, multicenter study
AU - Jolliet, Philippe
AU - Tassaux, Didier
AU - Roeseler, Jean
AU - Burdet, Luc
AU - Broccard, Alain
AU - D'Hoore, William
AU - Borst, François
AU - Reynaert, Marc
AU - Schaller, Marie Denise
AU - Chevrolet, Jean Claude
PY - 2003/3/1
Y1 - 2003/3/1
N2 - Objective: To study whether noninvasive pressure support ventilation (NIPSV) with helium/oxygen (He/oxygen), which can reduce dyspnea, Paco2, and work of breathing more than NIPSV with air/oxygen in decompensated chronic obstructive pulmonary disease, could have beneficial consequences on outcome and hospitalization costs. Design: Prospective, randomized, multicenter study. Setting: Intensive care units of three tertiary care university hospitals. Patients: All patients with chronic obstructive pulmonary disease admitted to the intensive care units for NIPSV during a 24-month period. Interventions: Patients were randomized to NIPSV with air/oxygen or He/oxygen. NIPSV settings, number of daily trials, decision to intubate, and intensive care unit and hospital discharge criteria followed standard practice guidelines. Results: A total of 123 patients (male/female ratio, 71:52; age, 71 ± 10 yrs, Acute Physiology and Chronic Health Evaluation II, 17 ± 4) were included. Intubation rate (air/oxygen 20% vs. He/oxygen 13%) and length of stay in the intensive care unit (air/oxygen 6.2 ± 5.6 vs. He/oxygen 5.1 ± 4 days) were comparable. The post-intensive care unit hospital stay was lower with He/oxygen (air/oxygen 19 ± 12 vs. He/oxygen 13 ± 6 days, p < .002). Cost of NIPSV gases was higher with He/oxygen, but total hospitalization costs were lower by $3,348 per patient with He/oxygen. No complications were associated with the use of He/oxygen. Conclusion: He/oxygen did not significantly reduce intubation rate or intensive care unit stay, but hospital stay was shorter and total costs were lower. He/oxygen NIPSV can be safely administered and could prove to be a cost-effective strategy.
AB - Objective: To study whether noninvasive pressure support ventilation (NIPSV) with helium/oxygen (He/oxygen), which can reduce dyspnea, Paco2, and work of breathing more than NIPSV with air/oxygen in decompensated chronic obstructive pulmonary disease, could have beneficial consequences on outcome and hospitalization costs. Design: Prospective, randomized, multicenter study. Setting: Intensive care units of three tertiary care university hospitals. Patients: All patients with chronic obstructive pulmonary disease admitted to the intensive care units for NIPSV during a 24-month period. Interventions: Patients were randomized to NIPSV with air/oxygen or He/oxygen. NIPSV settings, number of daily trials, decision to intubate, and intensive care unit and hospital discharge criteria followed standard practice guidelines. Results: A total of 123 patients (male/female ratio, 71:52; age, 71 ± 10 yrs, Acute Physiology and Chronic Health Evaluation II, 17 ± 4) were included. Intubation rate (air/oxygen 20% vs. He/oxygen 13%) and length of stay in the intensive care unit (air/oxygen 6.2 ± 5.6 vs. He/oxygen 5.1 ± 4 days) were comparable. The post-intensive care unit hospital stay was lower with He/oxygen (air/oxygen 19 ± 12 vs. He/oxygen 13 ± 6 days, p < .002). Cost of NIPSV gases was higher with He/oxygen, but total hospitalization costs were lower by $3,348 per patient with He/oxygen. No complications were associated with the use of He/oxygen. Conclusion: He/oxygen did not significantly reduce intubation rate or intensive care unit stay, but hospital stay was shorter and total costs were lower. He/oxygen NIPSV can be safely administered and could prove to be a cost-effective strategy.
KW - Chronic obstructive pulmonary disease
KW - Heliox
KW - Helium
KW - Mechanical ventilation
KW - Noninvasive ventilation
KW - Outcome
UR - http://www.scopus.com/inward/record.url?scp=0037350202&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037350202&partnerID=8YFLogxK
U2 - 10.1097/01.CCM.0000055369.37620.EE
DO - 10.1097/01.CCM.0000055369.37620.EE
M3 - Article
C2 - 12627000
AN - SCOPUS:0037350202
SN - 0090-3493
VL - 31
SP - 878
EP - 884
JO - Critical care medicine
JF - Critical care medicine
IS - 3
ER -